Emerald Advisers LLC lifted its stake in shares of Vital Farms, Inc. (NASDAQ:VITL - Free Report) by 106.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 706,440 shares of the company's stock after buying an additional 364,837 shares during the period. Emerald Advisers LLC owned about 1.64% of Vital Farms worth $24,775,000 at the end of the most recent quarter.
Other hedge funds also recently modified their holdings of the company. Harbor Capital Advisors Inc. bought a new stake in Vital Farms during the third quarter worth $1,798,000. Emerald Mutual Fund Advisers Trust lifted its holdings in Vital Farms by 93.9% during the third quarter. Emerald Mutual Fund Advisers Trust now owns 531,676 shares of the company's stock worth $18,646,000 after acquiring an additional 257,492 shares during the period. DekaBank Deutsche Girozentrale lifted its holdings in Vital Farms by 27.0% during the third quarter. DekaBank Deutsche Girozentrale now owns 8,301 shares of the company's stock worth $291,000 after acquiring an additional 1,763 shares during the period. CWC Advisors LLC. bought a new stake in Vital Farms during the third quarter worth $240,000. Finally, Dakota Wealth Management bought a new stake in Vital Farms during the third quarter worth $200,000. Hedge funds and other institutional investors own 98.59% of the company's stock.
Insider Activity at Vital Farms
In related news, CEO Russell Diez-Canseco sold 44,653 shares of the business's stock in a transaction dated Monday, October 14th. The stock was sold at an average price of $40.07, for a total transaction of $1,789,245.71. Following the completion of the transaction, the chief executive officer now directly owns 537,349 shares in the company, valued at $21,531,574.43. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, insider Matthew Ohayer sold 24,000 shares of the business's stock in a transaction dated Monday, October 21st. The stock was sold at an average price of $39.09, for a total transaction of $938,160.00. Following the completion of the transaction, the insider now directly owns 7,194,777 shares in the company, valued at $281,243,832.93. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Russell Diez-Canseco sold 44,653 shares of the business's stock in a transaction dated Monday, October 14th. The stock was sold at an average price of $40.07, for a total value of $1,789,245.71. Following the transaction, the chief executive officer now owns 537,349 shares of the company's stock, valued at approximately $21,531,574.43. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 27.60% of the stock is currently owned by corporate insiders.
Vital Farms Stock Performance
Shares of VITL traded down $0.12 during mid-day trading on Friday, hitting $34.56. The stock had a trading volume of 598,734 shares, compared to its average volume of 1,144,461. The company has a debt-to-equity ratio of 0.04, a current ratio of 3.50 and a quick ratio of 3.03. Vital Farms, Inc. has a 52 week low of $11.18 and a 52 week high of $48.41. The firm has a market cap of $1.49 billion, a P/E ratio of 32.60 and a beta of 0.97. The business has a fifty day moving average price of $34.79 and a 200-day moving average price of $36.36.
Vital Farms (NASDAQ:VITL - Get Free Report) last released its quarterly earnings data on Thursday, August 8th. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.20 by $0.16. Vital Farms had a return on equity of 22.77% and a net margin of 8.70%. The company had revenue of $147.39 million for the quarter, compared to analyst estimates of $138.41 million. During the same period in the previous year, the company posted $0.15 EPS. The firm's revenue for the quarter was up 38.5% compared to the same quarter last year. On average, equities research analysts expect that Vital Farms, Inc. will post 1.11 EPS for the current year.
Wall Street Analysts Forecast Growth
A number of brokerages recently commented on VITL. TD Cowen upgraded Vital Farms from a "hold" rating to a "buy" rating and set a $44.00 price target on the stock in a report on Friday, August 9th. DA Davidson lifted their price target on Vital Farms from $44.00 to $48.00 and gave the stock a "buy" rating in a report on Thursday, October 10th. Finally, Stifel Nicolaus lowered their target price on Vital Farms from $42.00 to $34.00 and set a "hold" rating on the stock in a research note on Friday, August 9th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, Vital Farms currently has an average rating of "Moderate Buy" and a consensus price target of $35.20.
Read Our Latest Stock Analysis on VITL
About Vital Farms
(
Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Read More
Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.